{
  "id": 3590182,
  "title": "GLP-1s May Offer Benefit in Ulcerative Colitis, Real-World Data Suggest",
  "url": "https://urgent.news/2026/08/26/glp-1s-may-offer-benefit-in-ulcerative-colitis-real-world-data-suggest",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T20:46:53.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/gastroenterology/inflammatoryboweldisease/122775"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The use of GLP-1 receptor agonists was linked to improved remission rates in patients with ulcerative colitis, a retrospective cohort study suggested. Among 300 patients with ulcerative colitis, use of liraglutide (Victoza...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}